Prismasari, S., Kim, H. J., Hong, J. H., & Kang, J. Y. (2026). Therapeutic Potential of Allomyrinasin in Oral Squamous Cell Carcinoma via Decreased NBC Activity. Pharmaceutics, 18(5), 622. https://doi.org/10.3390/pharmaceutics18050622
Chicago Style (17th ed.) CitationPrismasari, Septika, Hyeong Jae Kim, Jeong Hee Hong, and Jung Yun Kang. "Therapeutic Potential of Allomyrinasin in Oral Squamous Cell Carcinoma via Decreased NBC Activity." Pharmaceutics 18, no. 5 (2026): 622. https://doi.org/10.3390/pharmaceutics18050622.
MLA (9th ed.) CitationPrismasari, Septika, et al. "Therapeutic Potential of Allomyrinasin in Oral Squamous Cell Carcinoma via Decreased NBC Activity." Pharmaceutics, vol. 18, no. 5, 2026, p. 622, https://doi.org/10.3390/pharmaceutics18050622.